The FX PostThe FX Post
    What's Hot

    Man charged in New York with 3-week kidnapping to try to steal Bitcoin

    May 30, 2025

    Goldman Sachs Expert Predicts Significant Gold Price Surge by 2026

    May 29, 2025

    Second suspect in New York bitcoin kidnapping surrenders to police

    May 28, 2025
    The FX Post The FX Post
    • Best Fx Robots
    • Forex
      • News
      • Forex 101
      • Forex Forecasts
      • Broker Reviews
    • Crypto
      • News
      • Crypto 101
      • Crypto Forecasts
      • Crypto Reviews
    • Indices
      • News
      • Analysis
      • Commodities
      • Reviews
    • Automated Trading
      • Forex Signals
      • Forex Robots
      • Copy Trading
    • Top
      • Best Forex Robots
    The FX PostThe FX Post
    Home » Moderna Stock Continues to Slide as Co-Founder Sells Shares
    News

    Moderna Stock Continues to Slide as Co-Founder Sells Shares

    October 16, 20232 Mins Read
    Facebook Twitter Pinterest LinkedIn Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Reddit

    Shares of Moderna Inc. are experiencing a fourth consecutive loss as co-founder and chair Noubar Afeyan sells shares, signaling a potential concern for investors.

    Stock Performance

    The stock, MRNA, experienced a significant drop of 6.2% in afternoon trading, making it the biggest loser in the S&P 500 index for the day. This decline puts the stock on track for its lowest close since November 18, 2020.

    Affirmation Amidst Concerns

    Despite the recent selloff, Moderna has affirmed its guidance, which was provided in August. The company expects COVID-vaccine sales to range between $6 billion to $8 billion by 2023. This affirmation is notable, particularly after Pfizer’s warning of a revenue shortfall due to lowered expectations for COVID product sales.

    Co-Founder’s Sales

    The decline in Moderna’s stock coincides with the sale of shares by co-founder Noubar Afeyan. On October 11, Afeyan sold 15,000 shares at an average price of $103.296, raising $1.55 million. This was part of a trading plan adopted in February 2023. Despite the sales, Afeyan still owns approximately 0.6% of the outstanding shares, holding 2.17 million shares.

    In total, Afeyan has sold 55,000 shares in September at an average price of $105.825, raising about $5.82 billion.

    Year-to-Date Performance

    Moderna’s stock has witnessed a significant decline of 48.7% since the beginning of the year. In comparison, Pfizer’s stock has dropped by 35.6%, while the S&P 500 has gained 14%.

    Conclusion

    As Moderna’s stock continues to slide and the co-founder sells shares, investors may be closely watching the company’s performance and future prospects. It remains to be seen how the market will respond to these developments.

    Markets are invaded by algorithms
    Secure your passive income with algo-based trading systems
    Learn more
    COVID-vaccine Investors Moderna S&P 500 stocks
    Share. Facebook Twitter Pinterest LinkedIn Reddit

    Related Posts

    Man charged in New York with 3-week kidnapping to try to steal Bitcoin

    May 30, 2025

    Goldman Sachs Expert Predicts Significant Gold Price Surge by 2026

    May 29, 2025

    Second suspect in New York bitcoin kidnapping surrenders to police

    May 28, 2025

    Apple to debut dedicated gaming app within days of Nintendo Switch 2’s arrival

    May 28, 2025
    Add A Comment

    Leave A Reply Cancel Reply

      −  1  =  5

    Best FX Post
    Best Forex Robots (Expert Advisors) 2021

    Best Forex Robots (Expert Advisors) 2022: Passive Income From Algo Trading Systems

    July 7, 2021

    Top 10 Lending Platforms for Crypto Loans

    June 1, 2022
    forex eurusd trading charts

    Top 10 Best Forex Brokers In All Times

    June 1, 2022
    Recent Posts
    • Man charged in New York with 3-week kidnapping to try to steal Bitcoin
    • Goldman Sachs Expert Predicts Significant Gold Price Surge by 2026
    • Second suspect in New York bitcoin kidnapping surrenders to police
    • Apple to debut dedicated gaming app within days of Nintendo Switch 2’s arrival
    • Satoshi Nakamoto, BlackRock, and TechBerry — a new investigation by Newsweek
    Featured Reviews

    Traders Connect Review

    May 18, 2023

    System Levels Review

    May 26, 2023
    TechBerry

    TechBerry Review: Pros, Cons, Recommendations

    September 18, 2021
    Categories
    • Analysis
    • Automated Trading
    • Best FX Post
    • Broker Reviews
    • Commodities
    • Copy Trading
    • Crypto
    • Crypto 101
    • Crypto Bots
    • Crypto Forecasts
    • Crypto Reviews
    • Crypto Robot
    • Forex
    • Forex 101
    • Forex Forecasts
    • Forex Robots
    • Forex Signals
    • Forex Signals
    • Guides
    • Indices
    • News
    • News
    • News
    • News
    • Reviews
    • Reviews
    • Uncategorized
    Twitter BlogLovin
    © 2025, Thefxpost.com.
    • Contact

    Type above and press Enter to search. Press Esc to cancel.